Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Stem Cell Therapy Market – Market Insights

Stem cells are derived from the human cells. Stem cell therapy is also known as regenerative medicine. Regenerative medicine refers to a group of biomedical approaches (such as tissue engineering), which involves adoption of stem cells. These therapies have the ability to regenerate human cells, tissues, or organs, in order to restore normal functioning of the body. Stem cell therapies are used in the treatment of spinal cord injury, Parkinson’s disease, sickle cell disease, diabetes, and heart diseases.

The global stem cell therapy market size was valued at US$ 7,313.6 million in 2018, and is expected to exhibit a CAGR of 21.1% over the forecast period (2019-2027).

Figure 1. Global Stem Cell Therapy Market Value (US$ Mn), by Region, 2018

Stem Cell Therapy  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing research and development activities are expected to boost growth of the stem cell therapy market

Increasing research and development activities by the market players are one of the major factors that are expected to drive growth of the stem cell therapy market over the forecast period. For instance, in July 2018, the Emory Orthopaedics & Spine Center, in collaboration with Sanford Health, Duke University, Andrews Institute, and Georgia Institute of Technology, received US$ 13 million grant from the Marcus Foundation for a multicenter clinical trial studying stem cell options for treating osteoarthritis. The Phase 3 trial was initiated in March 2019, and is expected to complete by December 2021. Moreover, in December 2017, Mayo Clinic initiated the clinical phase I study on safety and feasibility of mesenchymal stem cell therapy in patients with intracerebral hemorrhage. This therapy is used for treating acute spontaneous hemorrhagic stroke. The study is expected to complete by December 2020.

Moreover, increasing product launches by key players is expected to boost demand for stem cell therapy over the forecast period. For instance, in August 2017, LifeCell, a healthcare service provider, launched an advanced umbilical cord-stem cell collection kit which offers enhanced protection to neonatal stem cells from environmental damage and temperature fluctuations.

Figure 2. Global Stem Cell Therapy Market Share (%), by Cell Source, 2019 and 2027

Stem Cell Therapy  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Stem Cell Therapy Market - Regional Analysis

North America stem cell therapy market is expected to account for the largest market share over the forecast period, owing to increasing research and development activities by the market players in the region. For instance, in February 2018, City of Hope Medical Center, U.S. initiated clinical phase I study of the pre-transplant immunosuppressive therapy for haploidentical transplant in patients with sickle cell disease. The study is expected to complete by February 2023.

Moreover, Europe is expected to witness significant growth in the global stem cell therapy market over the forecast period, owing to increasing number of product approvals by regulatory authorities and rising number of clinical trials in the region. For instance, in November 2018, Novartis AG received an approval from the European Commission for its CAR-T (Kymriah) for treatment of B-cell acute lymphoblastic leukemia in pediatric and adult patients. Moreover, in January, 2019, the Center for Beta Cell Therapy in Diabetes and ViaCyte Inc. entered into a collaboration for their first European clinical trial involving human stem cell-derived implants among T1D patients. The trial was carried out by the Beta Cell Therapy Consortium with the support of Horizon 2020 grant from the European Commission.

Moreover, Asia Pacific is expected to witness significant growth in the stem cell therapy market over the forecast period, owing to increasing number of research programs and launch of new stem cell bank in the region. For instance, in March 2019, the Chinese Academy of Sciences (CAS) announced the launch of three stem cell clinic research programs for treatment of severe eye diseases and gynecological diseases. The program was registered by the National Health Commission and the National Medical Products Administration. The stem cell research programs are majorly focused on treatment of retinal pigment degeneration, ovarian dysfunction, and intrauterine adhesions in women. Moreover, in January 2018, Lifecell Biotechnology launched a stem cell bank in India, which preserves and provides umbilical cord stem cells for stem cell transplantation. In a stem cell transplantation therapy, damaged and diseased cell or tissues are replaced or repaired by using stem cells. Hence, increasing launches of stem cell banks is expected to drive the stem cell therapy market growth over the forecast period.

Key Players

Major players operating in the global stem cell therapy market include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Market Dynamics

Increasing expansion of facilities by market players for stem cell therapies is expected to propel growth of the stem cell therapy market over the forecast period. For instance, in January 2018, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies; and the shared services segment offers technical resources related to stem cell therapies.

Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2018, Procella Therapeutics and Smartwise, a medtech company entered into a collaboration with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca utilized Procella Therapeutics’ stem cell technology for the development of stem cell therapies in cardiovascular diseases. Moreover, in April, 2019, CelluGen Biotech and FamiCord Group collaborated to develop new stem cell-based drugs and advanced medical therapies (ATMP)

Key features of the study:

  • This report provides in-depth analysis of the stem cell therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2019 – 2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global stem cell therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global stem cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the stem cell therapy market

Detailed Segmentation:

  • Global Stem Cell Therapy Market, By Cell Source:
    • Adult Stem Cells
    • Induced Pluripotent Stem Cells
    • Embryonic Stem Cells
    • Others
  • Global Stem Cell Therapy Market, By Application:
    • Musculoskeletal Disorders
    • Wounds and Injuries
    • Cancer
    • Autoimmune disorders
    • Others
  • Global Stem Cell Therapy Market, By Region:
    • North America
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Cell Source:
        • Adult Stem Cells
        • Induced Pluripotent Stem Cells
        • Embryonic Stem Cells
        • Others
      • By Application:
        • Musculoskeletal Disorders
        • Wounds and Injuries
        • Cancer
        • Autoimmune disorders
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Magellan*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Medipost Co., Ltd
    • Osiris Therapeutics, Inc.
    • Kolon TissueGene, Inc.
    • JCR Pharmaceuticals Co., Ltd.
    • Anterogen Co. Ltd.
    • Pharmicell Co., Inc.
    • Stemedica Cell Technologies, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Cell Source
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Market Trends
    • Product Launch
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER’s Analysis
  4. Global Stem Cell Therapy Market, By Cell Source, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Adult Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Induced Pluripotent Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Embryonic Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Stem Cell Therapy Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Musculoskeletal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Wounds and Injuries
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Autoimmune disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Stem Cell Therapy Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Cell Source, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Magellan*
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medipost Co., Ltd
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Osiris Therapeutics, Inc.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kolon TissueGene, Inc.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • JCR Pharmaceuticals Co., Ltd.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anterogen Co. Ltd.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pharmicell Co., Inc.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Stemedica Cell Technologies, Inc.
        • Company Overview
        • Application Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 33 market data tables and 21 figures on "Stem Cell Therapy Market - Global forecast to 2027”.

Frequently Asked Questions

The global stem cell therapy market is estimated to surpass US$ 40.3 Billion by 2027.
Major players operating in the global stem cell therapy market include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.
Among cell source, adult stem cells segment held dominant position in the stem cell therapy market in 2018.
Increasing research and development activities by the market playersis one of the major factors that is expected to propel growth of the market over the forecast period.
The global stem cell therapy market is estimated to exhibit a CAGR of 21.1% over the forecast period.
Among regions, North Americais expected to hold dominant position in the global stem cell therapy market during the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner